These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 6693039
1. Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension. Westaby D, Bihari DJ, Gimson AE, Crossley IR, Williams R. Gut; 1984 Feb; 25(2):121-4. PubMed ID: 6693039 [Abstract] [Full Text] [Related]
2. Effect of propranolol on hepatic blood flow in normal and portal hypertensive rats. Hillon P, Blanchet L, Lebrec D. Clin Sci (Lond); 1982 Jul; 63(1):29-32. PubMed ID: 7083761 [Abstract] [Full Text] [Related]
3. Reductions in portal pressure by selective beta 2-adrenoceptor blockade in patients with cirrhosis and portal hypertension. Bihari D, Westaby D, Gimson A, Crossley I, Harry J, Williams R. Br J Clin Pharmacol; 1984 Jun; 17(6):753-7. PubMed ID: 6146330 [Abstract] [Full Text] [Related]
4. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis. García-Pagán JC, Escorsell A, Feu F, Bandi JC, Moitinho E, Casado M, Bosch J, Rodés J. J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729 [Abstract] [Full Text] [Related]
8. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis. Braillon A, Calès P, Lebrec D. Int J Clin Pharmacol Res; 1985 Apr; 5(4):223-8. PubMed ID: 4055165 [Abstract] [Full Text] [Related]
9. Daily variation in portal blood flow and the effect of propranolol administration in a randomized study of patients with cirrhosis. Alvarez D, de las Heras M, Abecasis R, Terg R, Gerona S, Albornoz L, Galdame O, Torres J, Mastai R. Hepatology; 1997 Mar; 25(3):548-50. PubMed ID: 9049196 [Abstract] [Full Text] [Related]
14. Comparative haemodynamic effects of betaxolol and propranolol in patients with cirrhosis. Braillon A, Lee SS, Valla D, Geoffroy P, Sauvanet JP, Lebrec D. Scand J Gastroenterol; 1988 Aug; 23(6):691-5. PubMed ID: 2902683 [Abstract] [Full Text] [Related]
15. Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive rats. Calès P, Braillon A, Girod C, Lebrec D. J Hepatol; 1985 Aug; 1(4):349-57. PubMed ID: 4056347 [Abstract] [Full Text] [Related]
19. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis. Garcia-Pagán JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodés J. Hepatology; 1990 Feb; 11(2):230-8. PubMed ID: 2307401 [Abstract] [Full Text] [Related]
20. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis. Feu F, Bordas JM, Luca A, García-Pagán JC, Escorsell A, Bosch J, Rodés J. Hepatology; 1993 Nov; 18(5):1082-9. PubMed ID: 8225212 [Abstract] [Full Text] [Related] Page: [Next] [New Search]